Dailypharm Live Search Close

[Reporter¡¯s view] Yuhan's CEO Lee made a big decision

By Lee, Seok-Jun | translator Choi HeeYoung

20.05.13 06:14:22

°¡³ª´Ù¶ó 0



Jung Hee Lee, Yuhan CEO, is due until March next year. This is due to the company's policy of having two consecutive terms in three years. It will end in March next year. since he started working in March 2015. Most CEOs make their performances within their tenure. This is because 'maximum performance since its founding' can be a 'decoration' for their career.

However, CEO Jung Hee Lee does not care about performance. Last year's (0.84%) and the first quarter's (0.35%) operating margin were the lowest, but the technology fee, which is a positive factor in earnings, is divided as conservatively as possible.

The recent business report confirms this trend. Yuhan extended the expiry date of L

Lee, Seok-Jun(wiviwivi@dailypharm.com)
If you want to see the full article, please JOIN US (click)